ICU Medical, Inc. (NASDAQ:ICUI) has received an average broker rating score of 2.20 (Buy) from the five brokers that cover the stock, Zacks Investment Research reports. Three research analysts have rated the stock with a hold recommendation and two have assigned a strong buy recommendation to the company. ICU Medical’s rating score has declined by 10% from three months ago as a result of various analysts’ ratings changes.

Analysts have set a 12-month consensus price objective of $175.67 for the company and are predicting that the company will post $0.73 EPS for the current quarter, according to Zacks. Zacks has also given ICU Medical an industry rank of 159 out of 265 based on the ratings given to related companies.

A number of research firms have commented on ICUI. BidaskClub downgraded ICU Medical from a “hold” rating to a “sell” rating in a research report on Thursday, August 24th. Zacks Investment Research cut ICU Medical from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 15th. Gabelli reissued a “buy” rating on shares of ICU Medical in a research note on Friday, August 11th. Finally, Sidoti cut ICU Medical from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 20th.

Shares of ICU Medical (ICUI) traded up 1.69% during mid-day trading on Friday, hitting $177.35. The stock had a trading volume of 101,762 shares. The firm has a 50 day moving average of $171.40 and a 200-day moving average of $162.77. The stock has a market cap of $3.52 billion, a P/E ratio of 71.03 and a beta of 0.36. ICU Medical has a one year low of $120.14 and a one year high of $178.20.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the Zacks’ consensus estimate of $0.58 by $0.06. ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The company had revenue of $331.51 million for the quarter, compared to analysts’ expectations of $318.30 million. During the same quarter in the previous year, the business posted $1.15 EPS. The business’s quarterly revenue was up 242.8% compared to the same quarter last year. Equities research analysts expect that ICU Medical will post $4.11 earnings per share for the current fiscal year.

In other news, VP Virginia Ruth Sanzone sold 1,784 shares of the business’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $174.47, for a total value of $311,254.48. Following the completion of the sale, the vice president now directly owns 102 shares of the company’s stock, valued at approximately $17,795.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Scott E. Lamb sold 2,998 shares of the business’s stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $170.13, for a total value of $510,049.74. Following the completion of the sale, the chief financial officer now directly owns 9,050 shares of the company’s stock, valued at $1,539,676.50. The disclosure for this sale can be found here. Insiders sold a total of 212,549 shares of company stock valued at $36,354,740 over the last three months. Company insiders own 15.90% of the company’s stock.

Several institutional investors have recently bought and sold shares of ICUI. Creative Planning lifted its holdings in shares of ICU Medical by 315.6% in the 1st quarter. Creative Planning now owns 665 shares of the medical instruments supplier’s stock valued at $102,000 after purchasing an additional 505 shares during the last quarter. Janney Montgomery Scott LLC lifted its holdings in shares of ICU Medical by 0.4% in the 1st quarter. Janney Montgomery Scott LLC now owns 1,607 shares of the medical instruments supplier’s stock valued at $245,000 after purchasing an additional 7 shares during the last quarter. Great West Life Assurance Co. Can lifted its holdings in shares of ICU Medical by 6.5% in the 1st quarter. Great West Life Assurance Co. Can now owns 21,104 shares of the medical instruments supplier’s stock valued at $3,222,000 after purchasing an additional 1,280 shares during the last quarter. State Board of Administration of Florida Retirement System lifted its holdings in shares of ICU Medical by 1.9% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 7,080 shares of the medical instruments supplier’s stock valued at $1,081,000 after purchasing an additional 130 shares during the last quarter. Finally, First Trust Advisors LP lifted its holdings in shares of ICU Medical by 42.0% in the 1st quarter. First Trust Advisors LP now owns 10,188 shares of the medical instruments supplier’s stock valued at $1,556,000 after purchasing an additional 3,013 shares during the last quarter. 78.13% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/09/10/icu-medical-inc-icui-given-consensus-rating-of-buy-by-analysts.html.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Get a free copy of the Zacks research report on ICU Medical (ICUI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.